![Charles Winter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Winter
Chief Tech/Sci/R&D Officer at
JANUX THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Charles Winter is Chief Technical Officer at Janux Therapeutics, Inc. since 2021.
Former roles include Vice President-Chemistry, Manufacturing & Controls at AnaptysBio, Inc. (2020–2021), Vice President-Manufacturing & Controls at Synthorx, Inc. (2020), Head-Biologics at Denali Therapeutics, Inc. (2016–2018), Vice President-Manufacturing & Technology at Eden Biologics, Inc. (2015–2016), Director-Biologics Development at Gilead Sciences, Inc. (2011–2015), and Senior Group Leader & Principal Engineer at Genentech, Inc. (1994–2011).
Education includes undergraduate studies at the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-01 | 106,321 ( 0.18% ) | 2 M $ | 2026-05-30 |
Charles Winter active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Charles Winter
| Companies | Position | End |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 2021-02-28 |
| SYNTHORX, INC. | Corporate Officer/Principal | 2020-07-31 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 2018-05-31 |
| JHL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2016-07-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2015-05-31 |
Training of Charles Winter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
- Stock Market
- Insiders
- Charles Winter
Choose MarketScreener 
